At close: December 11 at 4:00:02 PM EST
Pre-Market: 4:10:49 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 17 | 13 | 17 | 17 |
| Avg. Estimate | 0.89 | 0.72 | 2.78 | 3.8 |
| Low Estimate | 0.8 | 0.59 | 2.63 | 3.42 |
| High Estimate | 1.08 | 1.05 | 2.99 | 4.44 |
| Year Ago EPS | 0.76 | 0.41 | 2.09 | 2.78 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 10 | 17 | 17 |
| Avg. Estimate | 311.51M | 317.17M | 1.19B | 1.36B |
| Low Estimate | 305.9M | 306.13M | 1.19B | 1.32B |
| High Estimate | 317.11M | 324.6M | 1.2B | 1.39B |
| Year Ago Sales | 284.68M | 278.65M | 1.06B | 1.19B |
| Sales Growth (year/est) | 9.43% | 13.82% | 12.46% | 14.37% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.7 | 0.38 | 0.56 | 0.69 |
| EPS Actual | 0.76 | 0.41 | 0.64 | 0.85 |
| Difference | 0.06 | 0.03 | 0.08 | 0.16 |
| Surprise % | 8.62% | 8.28% | 14.79% | 23.70% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.89 | 0.72 | 2.78 | 3.8 |
| 7 Days Ago | 0.89 | 0.72 | 2.78 | 3.77 |
| 30 Days Ago | 0.88 | 0.71 | 2.77 | 3.76 |
| 60 Days Ago | 0.85 | 0.71 | 2.59 | 3.56 |
| 90 Days Ago | 0.86 | 0.71 | 2.61 | 3.6 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 3 | -- | 1 |
| Up Last 30 Days | 1 | 4 | 1 | 2 |
| Down Last 7 Days | 1 | 2 | 1 | -- |
| Down Last 30 Days | 1 | 3 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PEN | 17.56% | 76.19% | 33.21% | 36.50% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | Citigroup: Neutral to Neutral | 12/11/2024 |
| Upgrade | Wells Fargo: Equal-Weight to Overweight | 12/11/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 12/9/2024 |
| Maintains | BTIG: Buy to Buy | 11/26/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/20/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 10/31/2024 |
Related Tickers
NARI Inari Medical, Inc.
58.21
+5.74%
IRTC iRhythm Technologies, Inc.
89.93
+3.49%
SGHT Sight Sciences, Inc.
3.9000
-0.26%
NVRO Nevro Corp.
4.3100
-0.69%
GMED Globus Medical, Inc.
82.94
+0.06%
PODD Insulet Corporation
273.47
-0.48%
INSP Inspire Medical Systems, Inc.
192.77
+1.77%
CNMD CONMED Corporation
73.32
-1.90%
BSX Boston Scientific Corporation
90.56
+0.40%
LIVN LivaNova PLC
51.49
+2.90%